跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,705 条关于
“JAK-STAT3”
全部
3,705
临床试验
2,502
药物
477
机构
147
资讯
579
去年
BerGenBio's Bemcentinib Enters Clinical Trial for Advanced Lung Adenocarcinoma
上个月
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for STAT3 Inhibitor TTI-109, Plans 2027 Trial
去年
First-in-Class STAT3 Inhibitor Shows Promise in Feline Head and Neck Cancer Trial with Human Applications
上个月
Progranulin and JAK2/STAT3 Synergy Identified as Potential Target to Overcome Differentiation Block in Leukemia
3个月前
JAK-STAT1-MED15 Axis Drives Melanocyte Dysfunction in Vitiligo, Study Reveals
9个月前
STAT3 Inhibitor Safety Concerns Highlight Alternative Approaches in IPF Drug Development
12天前
IL-10's Dual Role in Cancer Immunity: Review Maps Context-Dependent Framework as Phase III Failure Tempers Enthusiasm
去年
Tvardi Therapeutics Completes Merger with Cara, Advances STAT3 Inhibitor Programs for Fibrosis-Driven Diseases
去年
Kymera's STAT3 Degrader KT-333 Shows Promise Across Multiple Lymphomas and Solid Tumors
3年前
Tvardi Therapeutics to Present Phase 1 Trial Data of STAT3 Inhibitor TTI-101 at ASCO 2023
第 1 页,共 58 页
上一页
下一页